The Contingent Valuation Method in Health Care An Economic Evaluation of Alzheimer’s Disease

In the future, as our society becomes older and older, an increasing number of people will be confronted with Alzheimer's disease. Some will suffer from the illness themselves, others will see parents, relatives, their spouse or a close friend afflicted by it. Even now, the psychological and fi...

Full description

Main Authors: Nocera, Sandra, Telser, Harry (Author), Bonato, Dario (Author)
Corporate Author: SpringerLink (Online service)
Format: eBook
Language:English
Published: New York, NY Springer US 2003, 2003
Edition:1st ed. 2003
Series:Developments in Health Economics and Public Policy
Subjects:
Online Access:
Collection: Springer Book Archives -2004 - Collection details see MPG.ReNa
LEADER 03786nmm a2200385 u 4500
001 EB000616653
003 EBX01000000000000000469735
005 00000000000000.0
007 cr|||||||||||||||||||||
008 140122 ||| eng
020 |a 9781441991331 
100 1 |a Nocera, Sandra 
245 0 0 |a The Contingent Valuation Method in Health Care  |h Elektronische Ressource  |b An Economic Evaluation of Alzheimer’s Disease  |c by Sandra Nocera, Harry Telser, Dario Bonato 
250 |a 1st ed. 2003 
260 |a New York, NY  |b Springer US  |c 2003, 2003 
300 |a XI, 116 p  |b online resource 
505 0 |a Introduction -- 1. The contingent valuation method -- 2. Alzheimer's disease -- 3. Study objectives -- 4. Organization of the book -- 2: Study Design -- 1. Economic burden of Alzheimer's disease -- 2. Program ‘care’ - helping caregivers -- 3. Program ‘diagnosis’ - detecting AD early -- 4. Program ‘research’ - search for a cure of AD -- 5. Financing of the programs -- 3 : Elicitation Methods -- 1. Continuous contingent valuation format -- 2. Discrete contingent valuation format -- 3. Biases in contingent valuation studies 17 3.1 Yea-saying -- 4. Chosen elicitation techniques -- 4: Estimation Methods -- 1. Estimation methods for the discrete CV (DC and DM) -- 2. Estimation methods for payment card (PC) -- 5: Data -- 1. Sample structure and data collection -- 2. Descriptive statistics -- 6: Results -- 1. Program ‘care’ with taxes -- 2. Program ‘diagnosis’ -- 3. Program ‘research’ -- 7: Possible Reasons for Variation in the 
653 |a Microeconomics 
653 |a History of Economic Thought/Methodology 
653 |a Public health 
653 |a Public finance 
653 |a Economic history 
653 |a Public Economics 
653 |a Public Health 
653 |a Microeconomics 
700 1 |a Telser, Harry  |e [author] 
700 1 |a Bonato, Dario  |e [author] 
710 2 |a SpringerLink (Online service) 
041 0 7 |a eng  |2 ISO 639-2 
989 |b SBA  |a Springer Book Archives -2004 
490 0 |a Developments in Health Economics and Public Policy 
856 |u https://doi.org/10.1007/978-1-4419-9133-1?nosfx=y  |x Verlag  |3 Volltext 
082 0 |a 338.5 
520 |a In the future, as our society becomes older and older, an increasing number of people will be confronted with Alzheimer's disease. Some will suffer from the illness themselves, others will see parents, relatives, their spouse or a close friend afflicted by it. Even now, the psychological and financial burden caused by Alzheimer's disease is substantial, most of it borne by the patient and her family. Improving the situation for the patients and their caregivers presents a challenge for societies and decision makers. Our work contributes to improving the in decision making situation con­ cerning Alzheimer's disease. At a fundamental level, it addresses methodo­ logical aspects of the contingent valuation method and gives a holistic view of applying the contingent valuation method for use in policy. We show all stages of a contingent valuation study beginning with the design, the choice of elicitation techniques and estimation methods for willingness-to-pay, the use of the results in a cost-benefit analysis, and finally, the policy implica­ tions resulting from our findings. We do this by evaluating three possible programs dealing with Alzheimer's disease. The intended audience of this book are health economists interested in methodological problems of contin­ gent valuation studies, people involved in health care decision making, plan­ ning, and priority setting, as well as people interested in Alzheimer's disease. We would like to thank the many people and institutions who have pro­ vided their help with this project